| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MapLight Therapeutics, Inc. | Director | Voting Common Stock | 351,370 | $6,324,660 | $18.00 | 11 Feb 2026 | Direct |
| MapLight Therapeutics, Inc. | Director | Voting Common Stock | 31,672 | $603,985 | $19.07 | 10 Feb 2026 | Indirect |
| MapLight Therapeutics, Inc. | Director | Employee Stock Option (right to buy) | 139,610 | 27 Oct 2025 | Direct | ||
| MapLight Therapeutics, Inc. | Director | Series C Preferred Stock | 0 | 28 Oct 2025 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MPLT | MapLight Therapeutics, Inc. | 10 Feb 2026 | 2 | -$124,329 | 4 | Director | 12 Feb 2026, 17:45 |
| MPLT | MapLight Therapeutics, Inc. | 02 Feb 2026 | 2 | -$126,861 | 4 | Director | 04 Feb 2026, 21:15 |
| MPLT | MapLight Therapeutics, Inc. | 28 Jan 2026 | 4 | -$635,857 | 4 | Director | 30 Jan 2026, 20:50 |
| MPLT | MapLight Therapeutics, Inc. | 27 Oct 2025 | 4 | $0 | 4 | Director | 28 Oct 2025, 16:15 |
| MPLT | MapLight Therapeutics, Inc. | 25 Oct 2025 | 0 | $0 | 3 | Director | 27 Oct 2025, 16:36 |